[Federal Register Volume 79, Number 64 (Thursday, April 3, 2014)]
[Notices]
[Pages 18738-18739]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-07484]
=======================================================================
-----------------------------------------------------------------------
REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION
[BAC 416404]
Annual Public Meeting
ACTION: Notice of annual meeting.
-----------------------------------------------------------------------
SUMMARY: The Reagan-Udall Foundation for the Food and Drug
Administration (FDA), which was created by Title VI of the Food and
Drug Amendments of 2007, is announcing an annual open public meeting.
The Foundation will provide an overview of its history, project
updates, as well as projected activities going forward.
DATES: The open public meeting will be held on May 14, 2014, from 10
a.m. until 12 p.m. Interested persons may sign up to attend in person
and/or make comments at the meeting or submit written comments by
visiting http://www.ReaganUdall.org on or before May 6, 2014. Oral
comments from the public will be scheduled between approximately 11
a.m. and 12 p.m. Time allotted for each registrant will be 3 minutes.
The contact person will notify interested persons regarding their
request to speak by May 9, 2014. Written comments are encouraged. Those
individuals interested in making formal comments should notify the
contact person and submit a brief statement of the general nature of
the comments they wish to present. Written comments are encouraged
through May 12, 2014.
ADDRESSES: The public meeting will be held at 901 East Conference
Center, The Pew Charitable Trusts, 901 East St. NW., Washington, DC
20004.
FOR FURTHER INFORMATION CONTACT: Jane Reese-Coulbourne, Reagan-Udall
Foundation for the FDA, 202-828-1206, [email protected].
SUPPLEMENTARY INFORMATION:
I. Background
The Reagan-Udall Foundation for the FDA (the Foundation) is an
independent 501(c)(3) not-for-profit organization
[[Page 18739]]
created by Congress to advance the mission of FDA to modernize medical,
veterinary, food, food ingredient, and cosmetic product development;
accelerate innovation; and enhance product safety. With the ultimate
goal of improving public health, the Foundation provides a unique
opportunity for different sectors (FDA, patient groups, academia, other
government entities, and industry) to work together in a transparent
way to create exciting new research projects to advance regulatory
science.
The Foundation acts as a neutral third party to establish novel,
scientific collaborations. Much like any other independently developed
information, FDA evaluates the scientific information from these
collaborations to determine how Reagan-Udall Foundation projects can
help the Agency to fulfill its mission.
The Foundation's projects include: The Innovation in Medical
Evidence Development and Surveillance (IMEDS) Program, methods for
using observational electronic health care data for postmarket evidence
generation, including postmarket safety surveillance; the Systems
Toxicology Project, an evaluation of a systems biology approach to
preclinical safety testing; and the Critical Path to Tuberculosis
Multidrug Regimens (CPTR) Project, looking at new ways to develop
tuberculosis combination therapies. The Foundation seeks comments on
these and other potential topics for future activities.
II. Agenda
The Foundation will be providing an overview of its history,
project updates, as well as projected activities going forward. Find
the Meeting Agenda at http://www.ReaganUdall.org.
Dated: March 31, 2014.
Jane Reese-Coulbourne,
Executive Director, Reagan-Udall Foundation for the FDA.
[FR Doc. 2014-07484 Filed 4-2-14; 8:45 am]
BILLING CODE 4164-04-P